"Wants an Earlier Date Than November 17"

Samsung Biologics proposed a date to resume negotiations with the Sangsaeng Labor Union, which is staging its second partial strike, but the two sides failed to agree on one. As the number of participating workers and departments grows, the labor dispute appears to be dragging on.

A view of Samsung Biologics' headquarters in Yeonsu-gu, Incheon. Yonhap News Agency

A view of Samsung Biologics' headquarters in Yeonsu-gu, Incheon. Yonhap News Agency

View original image

According to industry sources on November 12, Samsung Biologics proposed resuming negotiations with the union on November 17, but the union said it would not accept the proposal. The union is calling for negotiations to take place sooner, and the two sides have yet to reach agreement on a date. A Samsung Biologics union representative said, "Management proposed resuming negotiations on November 17, but we did not respond that we would accept," adding, "We have no plans to accept the proposal as it stands."


The departments participating in the union's strike have been expanding at three-day intervals. According to the labor action guidelines the union distributed on November 12, seven departments, including the Test Method Technology Transfer Group, the Non-Routine Testing Group, and the Bioassay Testing Team, were added to the strike starting at midnight on November 12. The union initially launched the strike in departments including the Raw Material Testing Team, the Microbiology Group, and Manufacturing Quality Assurance (MFG QA) Groups 1-3, then expanded the list of affected departments in stages. As a result, the number of participating workers has risen from an initial 400 to 500. The union plans to continue the strike in the newly added departments through December 4.


The union has been staging its second partial strike since November 6, demanding wage increases and improved benefits. It is seeking a 9.5% increase in base pay and the allocation of 15% of annual pretax operating profit to a performance bonus pool. Management has offered an average increase of 6.2% and an incentive payment of 6 million won per employee. The union previously held the company's first-ever full-scale strike from May 1 to 5. The company estimated that production halts at some production lines at the time resulted in losses of about 150 billion won.



A Samsung Biologics representative said, "We are keeping channels of communication open to reach an amicable resolution to the wage and collective bargaining negotiations, and our commitment to reaching an agreement through negotiations remains unchanged." The representative added, "We will do our utmost to keep operations running and maintain quality stability so that patients and clients are not affected."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing